Newman Advisors

Chia-Lin, Jeff Wang, Bio-tech Advisor who is a famous world class Bio expert. Has been Chief Sientific Officers and President in many well known enterprises. In 2008-2014, he serves as President in DCB (Development Center for Bionology). DCB is a key bio research center in Taiwan. He lead 350-420 people in R&D, business development, and administration. Several major achievements include: To transform DCB into a new drug translational research institute working closely with academic institutes and industries; Top management recruiting (2 VPs, 3 Executive Directors, 1 Director); Tox facility and biologics CGMP facility spin-offs; DCB 5-year (2013-2017) strategic planning; 2-4 IND/clinical trial filing/yr; etc. Very well connection with Government, Academy, and Industry.


  • 1978-1979, Research Associate, Department of Chemistry, Harvard University
  • 1977 Ph.D., Department of Chemistry, University of Pittsburgh, Pittsburgh, PA
  • 1971 B.S., Department of Chemistry, National Taiwan University, Taipei, Taiwan

Professional Experience:

  • 2014 August-Present: Senior Vice President, CHO Pharma, Inc.
  • 2008 December-2014 July: President, Development Center for Biotechnology (DCB).
  • 2007 September-2008 November: Chief Scientific Officer, Microbio Co., Ltd.
  • 2007 May-July: Chief Scientific Officer, Wisdom Pharmaceutical Co., Ltd. (China)
  • 2006-2007: Vice President and R&D Director General, Development Center for Biotechnology
  • 2000-2005: Director, U.S. East Coast Office, Development Center for Biotechnology
  • 1997-2000: Science Advisor (Biotechnology & Pharmaceutical), Department of Industrial Technology, Ministry of Economic Affairs (Taiwan)
  • 1992-1996: Director, Natural Product & Medicinal Chemistry, Development Center for Biotechnology (Taiwan)
  • 1991-1992: Principal Research Scientist, The DuPont Merck Pharmaceuticals Co.
  • 1985-1990: Senior Research Chemist, DuPont Medical Products Department
  • 1979-1985: Research Chemist, DuPont Central Research and Development Department

Patents & Publications:

Total 15 US Patents and 42 Publications

Evan Lin, Automation Tech Advisor who is a well know expert in ICT technology field. He was the VP and CTO for the world class industrial PC company, Advantech Co. Serving the company for about 20 years. Exceptional contribution to the company and also to the whole industry. Got EE graduate degree from the best school in Taiwan, NTU. Specialize in industrial PC, Robotics, automation, ICT applications, etc.

Professional Experience

  • Industrial Automation Group, Advantech Co., Ltd. — Jan. 1996 – Feb. 2013
    • Vice President & Chief Technology Officer, Jul. 2007 – Feb. 2013
      • Took charge Enterprise-Academy Cooperation Projects on New Technologies.
      • Transformed R&D Center in Beijing to Profit-driven Product Business Units.
      • Led R&D Teams to Develop Innovative Products in Computing and Automation Fields.
    •  R&D Vice President, Jan. 2003 – Jun. 2007
      • Led R&D Teams to Develop the state-of-art Computing and Automation Products in the Internet Age.
      • Set up R&D Centers in Beijing and Xi-An.
  •  Anco Technologies Inc. — Aug. 1988 – Dec. 1995
    • Manager, Software Automation Department
      • Set up 1st Profitable Department in Company and High Market Share in CASE (Computer Aided Software Engineering) S/W Business in Taiwan.


National Taiwan University, Taipei, Taiwan, Master of Electrical Engineering — Sept. 1984 – Jun. 1986

Andrew Wo, Medical Device Advisor who has current roles as below:

  • Professor, Institute of Applied Mechanics, National Taiwan University (NTU)
  • Associate Dean, Research and Development, NTU
  • Director, Center for Industry-Academia Collaboration, NTU
  • Director, NTU Innovation Incubation Center
  • Director, Nano-Electro-Mechanical-Systems (NEMS) Research Center, NTU
  • Deputy Secretary General, Institute of Engineering Education Taiwan (IEET), a Washington Accord Signatory
  • Deputy Chair, Washington Accord


  • Bachelor (B.S.) in Engineering, University of Virginia, U.S.A., 1982
  • Master (M.S.) in Engineering, Massachusetts Institute of Technology, U.S.A., 1986
  • Doctorate (Ph.D.) in Engineering, Massachusetts Institute of Technology, USA, 1990

Professional Activities (representative)

  • Member – American Associate for Cancer Research
  • Chair, Washington Accord review panel to Russia (Association for Engineering Education Russian), worked with Canada and Korea to review Russia’s engineering education system, 2009-2012
  • Dean, Research and Development, National University of Kaohsiung, 2009-2011
  • Discovery Channel, showcased our innovative microfluidics technology on our Sperm Chip, 2011
  • Program Chair, Annual Conf. of International Association of University Presidents (IAUP), 2009
  • Workgroup member, Federation of Engineering Institutions of Asia and the Pacific (FEIAP), 2009
  • Chair and evaluator, accreditation of engineering educational programs via Institute of Engineering Education Taiwan (IEET), 2006-
  • Life-time Member, Chinese Institute of Mechanics

 Invited/Keynote Speech (representative)

  • Keynote speech, European Network for Accreditation of Engineering Education, 2nd Conference, “New Developments at the International Engineering Alliance and within Asia,” Leuven, Belgium, 9/2013.
  • Keynote speech, Annual meeting, Accreditation Board of Engineering and Technology (USA), “Accreditation of Engineering Programs in Asia,” Florida, USA, 2006
  • Invited speech, Hong Kong University of Science and Technology, “Microfluidics Technology to Detect Rare Cells in Whole Blood and other Clinical Applications,” 2010
  • Invited speech, Chinese University of Hong Kong, “Applications of Microfluidics for Detections of Circulating Tumor Cells,” 2010


  • Teaching Excellence Award, National Taiwan University
  • Innovative Award, Institute for Biotechnology and Medical Industry
  • Best paper award, Biomedical Engineering Conference, Taipei, Taiwan
  • Hiwin Masters’ Thesis Research Award, Hiwin Cooperation
  • Research Excellence award, National Science Council, Taiwan


Comments are closed.